Video

Dr. Morrow on Patient Selection for Nipple Sparing Mastectomy

Monica Morrow, MD, discusses the factors that impact the decision to use nipple sparing mastectomy versus conventional mastectomy in patients with breast cancer. The decision to use a nipple sparing approach in patients is dependent on 2 considerations. These relate to the cancer as well as cosmetic appearance of the breast.

Monica Morrow, MD, chief of Breast Service at Memorial Sloan Kettering Cancer Center, discusses the factors that impact the decision to use nipple sparing mastectomy versus conventional mastectomy in patients with breast cancer. The decision to use a nipple sparing approach in patients is dependent on 2 considerations. These relate to the cancer as well as cosmetic appearance of the breast.

Because there is a higher likelihood of nipple involvement in patients with larger cancers closer to the nipple, the ideal candidate for nipple sparing mastectomy would be a patients with a small peripheral breast cancer. Studies have also shown that for those patients where HER2 is over expressed, they are more likely to have nipple involvement because of a higher association to ductal carcinoma in situ (DCIS), says Morrow.

In terms of cosmetic appearance, the decision to move forward with a nipple sparing procedure versus conventional approaches depend on the placement of the nipple. For example, those with larger breasts may be poorer candidates, says Morrow, compared with patients who have smaller breasts.

<<< View more from the 2019 Lynn Sage Breast Cancer Symposium

Related Videos
Sagar D. Sardesai, MBBS
DB-12
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Stephanie Graff, MD, and Chandler Park, FACP
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Neil Iyengar, MD, and Chandler Park, MD, FACP
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Rena Callahan, MD, and Chandler Park, MD, FACP